Revere Increases Data Focus on Canadian BioPharm, MedTech Stocks
The data, which includes information on companies' product pipelines, the status of clinical trials, and information on companies' relationships to competitors and suppliers, is being made available via the vendor's Revere Research analysis platform and Revere RealTime data system. The data is also available as part of the vendor's XML or CSV file-format Healthcare Events datafeed, which can be fed directly into firms' databases or trading models, such as for index or statistical arbitrage
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Data Management
A network of Cusip workarounds keeps the retirement industry humming
Restrictive data licenses—the subject of an ongoing antitrust case against Cusip Global Services—are felt keenly in the retirement space, where an amalgam of identifiers meant to ensure licensing compliance create headaches for investment advisers and investors.
LLMs are making alternative datasets ‘fuzzy’
Waters Wrap: While large language models and generative/agentic AI offer an endless amount of opportunity, they are also exposing unforeseen risks and challenges.
Cloud offers promise for execs struggling with legacy tech
Tech execs from the buy side and vendor world are still grappling with how to handle legacy technology and where the cloud should step in.
Bloomberg expands user access to new AI document search tool
An evolution of previous AI-enabled features, the new capability allows users to search terminal content as well as their firm’s proprietary content by asking natural language questions.
CDOs must deliver short-term wins ‘that people give a crap about’
The IMD Wrap: Why bother having a CDO when so many firms replace them so often? Some say CDOs should stop focusing on perfection, and focus instead on immediate deliverables that demonstrate value to the broader business.
BNY standardizes internal controls around data, AI
The bank has rolled out an internal enterprise AI platform, invested in specialized infrastructure, and strengthened data quality over the last year.
First Citizens used AI to retain SVB customers
The firm’s retention efforts involved using AI to monitor customer behavior and sentiment—including profanities.
LSEG–MayStreet: When good partnerships go bad
Waters Wrap: MayStreet’s founder and former CEO is suing LSEG for fraud and breach of contract. Anthony considers what the damage control might look like.
